KM Research Hub
← 返回论文库
无 KM 图 入排:排除 图源:开放图源暂不可得 入排置信度 0.98

Prediction of time to insulin initiation in gestational diabetes mellitus: a secondary analysis of the EMERGE trial.

Yueyun Zhu, Alberto Alvarez-Iglesias, Aoife M Egan, Andrew Smyth, Christine Newman, David Aguilar Macias, Declan Devane, Fidelma Dunne, Martin O'Donnell, Paula O'Shea, Paddy Gillespie, Andrew J Simpkin

Diabetes Res Clin Pract 231 113070

PMID41435972
PMCID-
DOI10.1016/j.diabres.2025.113070
发表日期2025-12-23
入排依据:未发现恶性肿瘤人群证据。
疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。
摘要

摘要

AIMS: Gestational diabetes mellitus (GDM) is a global health problem. Insulin therapy is recommended when lifestyle management fails to control blood glucose. We aim to predict the time to insulin initiation for women with GDM. METHODS: A random survival forest (RSF) model was developed to predict the time to insulin initiation among 413 women from the EMERGE trial, analysed separately for placebo and metformin groups. Maternal characteristics and early glucose data (collected during the two weeks after randomisation) were used as predictors. Decision curve analysis was performed to assess the net benefit of the model compared with default strategies. RESULTS: The RSF model had a concordance index (C-index) of 0.71 (95 % CI: 0.64-0.77), time-dependent AUC ≥0.70 and Brier score ≤0.2 for the placebo group, and a C-index of 0.72 (95 % CI: 0.64-0.80), time-dependent AUC ≥0.75 and Brier score ≤0.2 for the metformin group. The decision curve analysis showed the RSF provided a higher net benefit for both groups compared to default strategies across clinically relevant threshold probabilities. CONCLUSIONS: The RSF model effectively identified women at high risk of requiring insulin. The decision curve analysis could help clinicians to balance insulin initiation decisions. However, prospective validation is needed to confirm the generalisability of the model.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。